{"transactions":[{"id":993428,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-11-19T22:00:02.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":1517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the \"Shareholder Approval Date\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date."}],"balance_after":1517,"derivative":{"exercise_price":12.48,"expiration_date":"2035-11-17","underlying":"Common Stock","underlying_shares":1517},"source":{"system":"sec-edgar","filing":"0001683168-25-008561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316825008561/ownership.xml","form_type":"4"}},{"id":1543567,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-04-11T01:52:22.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The awards were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":147594,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001683168-24-002288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824002288/ownership.xml","form_type":"4"}},{"id":1543566,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-04-11T01:52:22.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The awards were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":129594,"derivative":{"exercise_price":0.2586,"expiration_date":"2034-04-08","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001683168-24-002288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824002288/ownership.xml","form_type":"4"}},{"id":1656411,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrant to purchase common stock","published_at":"2024-02-06T15:28:10.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024."}],"balance_after":112094,"derivative":{"exercise_price":0.3,"exercise_date":"2024-02-01","expiration_date":"2025-10-01","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001683168-24-000708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000708/ownership.xml","form_type":"4"}},{"id":1656410,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrant to purchase common stock","published_at":"2024-02-06T15:28:10.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024."}],"balance_after":78761,"derivative":{"exercise_price":0.3,"exercise_date":"2024-02-01","expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001683168-24-000708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000708/ownership.xml","form_type":"4"}},{"id":1656409,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-02-06T15:28:10.000Z","date":"2024-02-01","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":0.3,"value":9999.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024."}],"balance_after":43006,"source":{"system":"sec-edgar","filing":"0001683168-24-000708","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000708/ownership.xml","form_type":"4"}},{"id":1760962,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-10-12T22:01:19.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":39475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":45428,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":39475},"source":{"system":"sec-edgar","filing":"0001683168-23-007111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823007111/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-25"}},{"id":1773749,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-09-25T22:26:26.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":68961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":74914,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":68961},"source":{"system":"sec-edgar","filing":"0001683168-23-006684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823006684/ownership.xml","form_type":"4"}},{"id":1915446,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-21T11:58:55.000Z","date":"2023-04-19","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.7,"value":4250.0,"ownership":{"direct":true},"balance_after":9673,"source":{"system":"sec-edgar","filing":"0001683168-23-002562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823002562/ownership.xml","form_type":"4"}},{"id":1918815,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-17T12:17:37.000Z","date":"2023-04-10","kind":"purchase","planned":false,"acquired":true,"shares":7173,"price":0.74,"value":5308.02,"ownership":{"direct":true},"balance_after":7173,"source":{"system":"sec-edgar","filing":"0001683168-23-002424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823002424/ownership.xml","form_type":"4"}},{"id":2631564,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-07-16T21:00:33.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":178559,"derivative":{"exercise_price":1.8,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001683168-21-003000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316821003000/ownership.xml","form_type":"4"}},{"id":3108295,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":72876,"kind":"person","name":"Gumulka Jerzy","position":1,"cik":"0001793252","reported_name":"Gumulka Jerzy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-16T21:23:22.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":46559,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":146559,"derivative":{"exercise_price":2.47,"expiration_date":"2030-06-12","underlying":"Common Stock","underlying_shares":46559},"source":{"system":"sec-edgar","filing":"0001683168-20-001967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316820001967/ownership.xml","form_type":"4"}}]}